U.S. Retail REITs Stock News

If you are wondering whether Medtronic stock is attractively priced or just looks cheap after a rough patch, the recent valuation picture gives you a lot to weigh up. The share price closed at US$76.15 and has declined 11.6% over the past month, 20.7% year to date, and 9.1% over the last 12 months, which will catch the eye of anyone watching for changes in risk or potential upside. Recent coverage around Medtronic has focused on its position as a large medical equipment company at a time...

Wondering if Ameresco at around US$33.03 is still offering value after a strong run, or if you are arriving late to the story. The stock has posted returns of 10.2% over the past week, 27.7% over the past month, 7.7% year to date and 120.8% over the past year, while the 3 year and 5 year periods show declines of 23.6% and 36.7%. Recent price moves sit against a backdrop of ongoing attention on clean energy infrastructure companies and investor interest in how these businesses are positioned...

Qnity Electronics (Q) stock is back in focus after the company reported a record first quarter for fiscal 2026 and raised its full year sales and earnings guidance, highlighting strong demand across key end markets. See our latest analysis for Qnity Electronics. The latest record quarter and raised guidance come after a strong share price run, with an 85.02% year-to-date share price return and a 40.77% 3-month share price return, even though the 1-day share price return following the results...

Earlier this month, Twilio used its 2026 SIGNAL conference in San Francisco to launch a broad AI-focused upgrade, including Conversation Memory, Conversation Orchestrator, Conversation Intelligence, Agent Connect, a rebuilt console, Twilio Email, and enhanced Voice AI and data-residency features. This push to create continuous, context-rich conversations across channels highlights Twilio’s effort to move up the value chain from basic messaging toward more integrated, AI-enabled customer...

Q1 earnings and guidance reset the conversation Rollins (ROL) is back in focus after Q1 2026 revenue came in ahead of Wall Street forecasts, with long-term contracts and residential services underpinning the quarter and setting the tone for updated analyst views. See our latest analysis for Rollins. Even after the Q1 beat and upbeat messages from the recent Analyst/Investor Day, Rollins’s share price of $53.42 leaves the stock down 9.47% year to date. The 5 year total shareholder return of...

J&J Snack Foods Corp. recently reported second-quarter 2026 results showing sales of US$344.82 million and net income of US$1.68 million, both lower than a year earlier, alongside a completed repurchase of 259,889 shares for US$21.98 million. While earnings for both the quarter and six-month period weakened year on year, management also reduced the share count, which can modestly support per-share metrics. We’ll now examine how this softer revenue and earnings performance, paired with the...

Genesis Energy, L.P. recently reported first-quarter 2026 results, with sales rising to US$446.56 million from US$398.31 million a year earlier and net income improving to US$6.8 million from a very large net loss in the prior-year period. Alongside this operational rebound, the partnership awarded multi-year, cash-settled phantom units to its senior leadership team, tying their compensation more closely to long-term business performance. Against this backdrop of higher revenue and renewed...

Harmony Biosciences Holdings (HRMY) is back in focus after its latest quarterly report showed net income of US$32.49 million for the March 2026 quarter, lower than the US$45.56 million reported a year earlier. See our latest analysis for Harmony Biosciences Holdings. Despite the softer earnings and a series of routine governance updates at the 2026 Annual Meeting, the stock has retreated, with the share price down 16.44% over 90 days and the year to date share price return down 19.50%. The 1...

In May 2026, Innoviz Technologies reported first-quarter 2026 revenue of US$7.13 million versus US$17.39 million a year earlier, with net loss widening to US$26.2 million, while reaffirming full-year revenue guidance of US$67 million to US$73 million. A flurry of new agreements across defense and autonomous mobility, including framework deals with Kela Technologies and LOXO and an on-sensor software evaluation with an autonomous driving partner, highlights Innoviz’s push to diversify beyond...

Abercrombie & Fitch (ANF) is back on investor radars after its stock fell 6.9% as surging gas prices and historically weak consumer sentiment raised fresh questions about demand for discretionary apparel retailers. See our latest analysis for Abercrombie & Fitch. Beyond the latest 6.9% drop, the stock has been under pressure for months, with the share price down 25% over 30 days and the year to date share price return down 43%, even as the 3 year total shareholder return is around 3x. Recent...

In May 2026, Innovative Aerosystems, Inc. reported fiscal second-quarter results showing revenue of US$22.37 million and adjusted earnings per share of US$0.26, exceeding analyst expectations despite lower GAAP net income year-on-year. Alongside the earnings release, management highlighted an active acquisition pipeline, including interest in potential Honeywell divestitures, aiming to broaden its avionics portfolio and recurring aftermarket exposure. We’ll now examine how this earnings...

Wondering whether UWM Holdings at around US$3.00 is a bargain or a value trap? This article breaks down what the current price might be implying about the stock. The share price has been under pressure, with returns declining 11.2% over the past week, 23.5% over the past month, 32.0% year to date, and 24.3% over the past year. The 3 year and 5 year returns are down 25.8% and 45.8% respectively. Recent coverage around UWM Holdings has focused on the stock itself rather than any single...

Option Care Health, Inc. previously cut its 2026 guidance due to weaker patient retention and a changed therapy mix, prompting multiple securities law investigations and raising questions about its recent outlook. At the same time, insider share purchases and upcoming conference commentary from senior leadership add an extra layer of context for investors assessing the company’s future direction. With the guidance revision tied to weaker patient retention and therapy mix, we’ll examine how...

CF Industries Holdings (CF) stock is back in focus after the company reported stronger than expected quarterly sales and profits, and the company was highlighted for its position in the tight global nitrogen fertilizer market. See our latest analysis for CF Industries Holdings. The recent earnings beat, updated 2026 production guidance, and ongoing buybacks appear to be feeding into strong momentum, with a 32.31% 3 month share price return and a 166.05% 5 year total shareholder return...

MBX Biosciences recently reported a first-quarter 2026 net loss of US$23.52 million, released encouraging early obesity pipeline data, and named industry veteran Mark R. Soued as Chief Commercial Officer. The combination of once-monthly obesity candidates and a seasoned commercial leader with major launch experience marks an important shift toward preparing MBX’s pipeline for potential future commercialization. Next, we’ll examine how MBX’s once-monthly obesity trial results could influence...

AIAI Holdings (NasdaqGM:AIAI) completed a direct listing on the NASDAQ Global Market. The company has been added to the NASDAQ Composite Index following its listing. These steps expand AIAI Holdings' access to U.S. equity markets and index-linked capital. AIAI Holdings, now trading under the ticker NasdaqGM:AIAI, enters one of the most closely watched equity platforms globally at a time when index membership can influence both liquidity and investor mix. For readers tracking listed...

ADTRAN Holdings (ADTN) has drawn fresh attention after expanding its SDG 8700 Series with new Wi-Fi 7 platforms and reporting first quarter 2026 results that showed higher revenue and a smaller net loss than a year earlier. See our latest analysis for ADTRAN Holdings. The Wi-Fi 7 expansion and improved first quarter results have come alongside a 90-day share price return of 47.19% and a year-to-date share price return of 71.77%. The 1-year total shareholder return of 83.39% contrasts with a...

Brightstar Lottery (BRSL) just posted first quarter 2026 results that showed higher earnings on essentially flat revenue, reaffirmed its full year outlook and backed this up with a dividend, ongoing buybacks and contract wins. See our latest analysis for Brightstar Lottery. Despite the stronger first quarter earnings, Brightstar Lottery's share price is down 18.4% over the past month and 29.9% year to date, while the 1 year total shareholder return is down 19.4%. This points to fading...

Bristow Group Inc. recently reported first-quarter 2026 results, posting sales of US$388.71 million and net income of US$13.11 million, while reaffirming full-year 2026 revenue guidance of US$1.58 billion to US$1.69 billion. The company also confirmed it has completed a relatively small share repurchase program and is absorbing higher repair, maintenance, and fleet-retirement costs that are weighing on profitability despite solid revenue performance. We will now examine how reaffirmed...

Recent share performance and business backdrop International Paper (IP) has drawn investor attention after a period of weaker share performance, with the stock down 4% over the past day, 8% over the past week, and 18% over the past month. Over the past 3 months the share price has fallen 38%, while the 1-year total return is down 37%. In this market backdrop, investors are weighing the company’s current valuation against its reported revenue of US$24.3b and a net loss of US$2.6b. See our...

Earlier this week, UBS Group upgraded Corcept Therapeutics following increased confidence in Lifyoril, its investigational ovarian cancer therapy, while a senior executive reported bona fide gifts of company shares to family accounts. This combination of heightened optimism around an additional oncology asset and insider estate planning activity offers a fresh lens on Corcept’s evolving profile. We’ll now examine how UBS’s increased confidence in Lifyoril’s regulatory outlook may influence...

Why monday.com stock is back in focus monday.com (MNDY) is attracting fresh attention after reporting first quarter 2026 results that topped Wall Street expectations, paired with a reset outlook and a sweeping shift to an AI focused work platform. Sales for the quarter were US$351.27 million compared with US$282.25 million a year earlier, while net income was US$28.03 million versus US$27.43 million. Basic earnings per share from continuing operations came in at US$0.58, with diluted earnings...

In the first quarter of 2026, Target Hospitality Corp. reported higher sales of US$16.58 million and revenue of US$72.78 million, but its net loss widened to US$12.92 million and loss per share increased to US$0.13 compared with the prior year. A new multi-year contract expected to generate more than US$750 million in revenue and tied to AI infrastructure development prompted management to raise full-year 2026 guidance, signaling that long-term contract visibility is becoming increasingly...

Attention on Blaize Holdings (BZAI) has shifted sharply to legal and governance risk after a short seller accused the company of fraud related to a reported $50 million NeoTensr deal, prompting multiple law firm investigations. See our latest analysis for Blaize Holdings. Legal questions around the NeoTensr deal have coincided with sharp pressure on Blaize Holdings' share price, with a 1 day share price return of down 26% and a 7 day return of down 30%. This compares with a 3 year total...